anonymous
Guest
anonymous
Guest
Right sized depends on what title you have.. **DSI gave up on Savaysa.
Specialty: I guess "right sized"... For Movantik n Joke Welchol.
Striker: too big of territory n not enough voice for Savaysa. Movantik, got help.
Hospital: DEAD POSITION at DSI: don't apply!!! Savaysa lead for huge territories where now 1 rep for like 1/2 a state where 6 reps helped to launch it & still failed. Less than 2% market share in a year. Effient goes generic 4/2107 and Savaysa is a Dead product...for so so many reasons i can't list them all but I'll try.
1) CrCl issue
2) DVT/PE flawed indication
3) ABSOLUTLY NO PART D Coverage... And none to come.
4) ease of use of the other Factor Xa
5) 4th to market, 3rd in class w no differentiating evidence.
6) No P-Value in Indicated population. (Try explaining that...)
7) 1 rep per 1/2 of state.
Need I go on....
Sorry.... Forgot Base and IC from last post. Which are both worst in the industry from DSI... But they did raise them from dead last worst to just worst.... I guess anything up from horrid is good.
Specialty base: 70-80k( very high end) and laughable IC.
Striker Base: 80-90k (high end) laughable IC.
Hospital base: >100k (like 90-95k).... And will be let go in next layoff. *** Along w "Striker position) Also laughable IC and flawed DDD data.